Dronabinol

SYNDROS is indicated in adults for the treatment of: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS).

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS).
nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Do not take if: with a history of a hypersensitivity reaction to dronabinol. Reported hypersensitivity reactions to dronabinol include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing, throat tightness.
with a history of a hypersensitivity reaction to alcohol.
who are receiving, or have recently received, disulfiram- or metronidazole-containing products within 14 days. SYNDROS contains 50% (w/w) dehydrated alcohol and 5.5% (w/w) propylene glycol.

What it is used for

SYNDROS is indicated in adults for the treatment of:

anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS).
nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

Who should not take it

SYNDROS is contraindicated in patients:

with a history of a hypersensitivity reaction to dronabinol. Reported hypersensitivity reactions to dronabinol include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing, throat tightness.
with a history of a hypersensitivity reaction to alcohol.
who are receiving, or have recently received, disulfiram- or metronidazole-containing products within 14 days. SYNDROS contains 50% (w/w) dehydrated alcohol and 5.5% (w/w) propylene glycol.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Dronabinol; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/dronabinol
APA 7th: sofidex. (2026, August 2). Dronabinol. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/dronabinol
AMA 11th: Dronabinol. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/dronabinol

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.